Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy

By Caparros-Lefebvre D.   Sergeant N.   Lees A.   Camuzat A.   Daniel S.   Lannuzel A.   Brice A.   Tolosa E.   Delacourte A.   Duyckaerts C.  

Brain, Vol. 125, Iss. 4, 2002-04 ,pp. : 801-811

Oxford University Press

Access to resources Recommend Favorite

Fluvoxamine for the treatment of depression and parkinsonism in progressive supranuclear palsy

By Miyaoka Tsuyoshi   Seno Haruo   Inagaki Takuji   Horiguchi Jun  

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 1, 2002-03 ,pp. : 45-47

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

By Williams David R.  

Brain, Vol. 128, Iss. 6, 2005-06 ,pp. : 1247-1258

Oxford University Press

Access to resources Recommend Favorite

Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome

By Williams David R.  

Brain, Vol. 130, Iss. 6, 2007-06 ,pp. : 1566-1576

Oxford University Press

Access to resources Recommend Favorite

Commentary on: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP–parkinsonism, by D. Williams, R. de Silva, D. Paviour, et al . ( Brain -2004-01045.R1)

By Burn David J.  

Brain, Vol. 128, Iss. 6, 2005-06 ,pp. : 1235-1236

Oxford University Press

Access to resources Recommend Favorite